Skip to main content

Building

A better future

through education, skill development and research

LEARN MORE

Cannabinoids May Have a Vast Array of Anti-Cancer Effects

Previous research has shown that cannabinoids can help lessen side effects of anti-cancer therapies. Now a new British Journal of Pharmacology review has examined their potential for the direct treatment of cancer.

Wednesday, July 18, 2018 12:01 am EDT
"Clinical studies are now urgently needed to investigate the impact of cannabinoids on cancer growth and progression in patients."

Previous research has shown that cannabinoids can help lessen side effects of anti-cancer therapies. Now a new British Journal of Pharmacology review has examined their potential for the direct treatment of cancer.

Phytocannabinoids are the most notable type of cannabinoid, and they occur naturally in the cannabis plant. Studies have shown that cannabinoids may stop cancer cells from dividing and invading normal tissue, and they may block the blood supply to tumors. Some studies also indicate that cannabinoids may enhance the body’s immune response against the growth and spread of tumors.

“There is still a need for additional anti-cancer drugs. In this context accumulating data from preclinical models suggest that cannabinoids elicit anti-cancer effects on several levels of cancer progression,” said author Prof. Burkhard Hinz, of Rostock University Medical Center, in
Germany. “Clinical studies are now urgently needed to investigate the impact of cannabinoids on cancer growth and progression in patients."

Additional Information

Link to Study: https://onlinelibrary.wiley.com/doi/10.1111/bph.14426 

About Journal

The British Journal of Pharmacology is a broad-based journal giving leading international coverage of all aspects of experimental pharmacology. It publishes high quality original research and authoritative reviews. Each year a range of themed issues are published and a must-read supplement, the Concise Guide to Pharmacology, is published biennially.

The journal is now published in an online-only format. Issues are published fortnightly but are no longer printed; however, authors are still able to order offprints of their own articles through Author Services.

About Wiley 

Wiley, a global research and learning company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 210 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at www.wiley.com.

Peer Reviewed           Review           Human

Multimedia Files:

Preview image

Contact:

Penny Smith (UK) +44 (0) 1243 770448
sciencenewsroom@wiley.com
Follow us on Twitter @WileyNews

Business Wire NewsHQsm